Skip to content
Screener

Inspire Medical Systems INSP Q4 2025 Annual earnings

Reported February 11, 2026 · After market close

Revenue$269.1MBeat by $3.4M
EPS$1.65Beat by $0.96
Revenue estimate$265.7M
EPS estimate$0.69

Next report

Nov 2, 2026 (in a month)
Revenue estimate$204.2M
EPS estimate$0.11

Financials

Q4 2025

Income statement

See full
Revenue$269.1M+12.2%
Gross profit$233.0M+14.4%
Operating income$46.1M+44.6%
Net income$136.1M+286%
EPS (diluted)$4.58+298%

Balance sheet

See full
Cash & equivalents$104.8M-30.2%
Total debt$32.2M+1.1%
Total equity$781.2M+13.3%
Total assets$907.3M+12.2%

Cash flow

See full
Operating cash flow$52.5M-24.2%
CapEx$10.7M+51.6%
Free cash flow$41.8M-32.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$2.68B-51.8%
Enterprise value$2.61B-52.0%
P/E18.4×-85.4×
P/S2.9×-4.0×

Profitability

See full
Gross margin85.4%+0.7pp
Operating margin5.6%+1.1pp
Net margin15.9%+9.3pp
FCF margin8.6%-2.7pp

Returns & leverage

See full
Return on equity19.8%+11.3pp
Debt / equity0×0.0×
Current ratio6.1×-1.1×

Segments

By segment

See full
Operating Segment$269.1M+12.2%

FAQ

When did Inspire Medical Systems report Q4 2025 earnings?
Inspire Medical Systems (INSP) reported Q4 2025 earnings on February 11, 2026 after market close.
What were Inspire Medical Systems's Q4 2025 revenue and EPS?
Inspire Medical Systems reported revenue of $269.1M and eps of $1.65 for Q4 2025.
Did Inspire Medical Systems beat estimates in Q4 2025?
Revenue beat the consensus estimate of $265.7M by $3.4M. EPS beat the consensus estimate of $0.69 by $0.96.
How did Inspire Medical Systems's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.2% from $239.7M a year earlier and eps grew 43.5% from $1.15.
Where can I find Inspire Medical Systems's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001609550-26-000012) and the 10-K periodic report (0001609550-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.